Results 91 to 100 of about 48,070 (253)

A prospective study of the clarithromycin-digoxin interaction in elderly patients

open access: yes, 2002
The study was a prospective observational trial carried out to assess the clarithromycin–digoxin interaction in elderly patients chronically taking digoxin. Digoxin concentrations were determined before and after concomitant treatment with clarithromycin.
Zapater, Pedro   +5 more
core   +1 more source

Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Digoxin use was shown to be associated with an increased risk of cardiovascular events in atrial fibrillation (AF). We hypothesized that digoxin may affect cardiovascular risk by increasing platelet activation.
Daniele Pastori   +10 more
doaj   +1 more source

Real‐World Performance of a Novel Wearable Cardioverter‐Defibrillator System: Primary Results From a National Prospective Post‐Approval Registry Study (ACE‐PAS)

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
In this prospective study of 21 612 patients, the ASSURE wearable cardioverter‐defibrillator met prespecified effectiveness and safety endpoints, demonstrating high VT/VF shock conversion success, a low rate of inappropriate shocks and false alarms, and high patient adherence in routine clinical practice.
Jeanne E. Poole   +8 more
wiley   +1 more source

A pharmacokinetic study of digoxin holiday dosing practice in Egypt: A prospective-randomized trial

open access: yesBulletin of Faculty of Pharmacy Cairo University, 2016
Background: Because of the narrow therapeutic index of digoxin, most cardiologists in Egypt give digoxin holiday for atrial fibrillation and heart failure, it is not clear if the interrupted digoxin regimens are effective since serum digoxin ...
S.A. Alshabasy   +3 more
doaj   +1 more source

Parasympathetic dysfunction assessed by deep‐breathing CVR‐R is associated with early discontinuation of oral semaglutide in type 2 diabetes: A multicenter retrospective study

open access: yesJournal of Diabetes Investigation, EarlyView.
Lower CVR‐R during deep breathing (CVR‐R_DB), a marker of parasympathetic function, was associated with early discontinuation of oral semaglutide due to nausea and/or vomiting in patients with type 2 diabetes. CVR‐R_DB may support risk stratification at treatment initiation.
Kazuma Ogiso   +5 more
wiley   +1 more source

Postmortem digoxin-like immunoreactive substances (DLIS) in patients not treated with digoxin

open access: yes, 1999
1 Endogenous digoxin-like immunoreactive substances (DLIS) cross-react in immunoassays of digoxin. The postmortem rise in digoxin levels in patients treated with the drug may be due to its redistribution.
Alla Tsipiniuk   +2 more
core   +1 more source

Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma

open access: yesEuropean Thyroid Journal
Objective: Patients with non-medullary thyroid carcinoma (NMTC) that are refractory to radioactive iodine (RAI) have a poor prognosis. Strategies for restoring the ability to take up iodine, so-called redifferentiation, are promising but not suitable for
Pepijn van Houten   +6 more
doaj   +1 more source

Electrophysiologic similarities of overdose between digoxin and bufadienolides found in a Chinese aphrodisiac

open access: yesJournal of Arrhythmia, 2017
Classically derived from toad venom, bufadienolides are a group of cardioactive steroids with properties similar to digoxin. Some traditional Chinese medications, including several aphrodisiacs, contain bufadienolides.
Maxwell Bressman   +3 more
doaj   +1 more source

Hip Fracture Risk of Lemborexant and Suvorexant in Comparison With Z‐Drugs: A Target Trial Emulation

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Lemborexant and suvorexant are widely used dual orexin receptor antagonists (DORAs) for the pharmacological treatment of insomnia. Although they are generally considered safer than benzodiazepine receptor agonists (Z‐drugs) regarding adverse events including hip fractures, evidence from direct comparisons remains limited. This study
Yuichiro Matsuo   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy